Vaxxas is a privately-held biotechnology company focused on enhancing the performance of existing and next-generation vaccines with its Nanopatch technology platform. Vaxxas' Nanopatch contains an ultra-high density array of projections – invisible...Show all
Company (Alive / Active)
Phone:
47 Thorndike Street
Suite B1-1
Cambridge, 02141
Massachusetts, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Delivery device | Jan 09, 2017 | Aug 25, 2020 | Patent |
Coating method | Nov 12, 2015 | Jul 17, 2018 | Patent |
Patch applying apparatus | Jul 14, 2011 | Apr 17, 2018 | Patent |
Method of delivering material or stimulus to a biological subject | Oct 03, 2011 | Feb 13, 2018 | Patent |
Differential coating of microprojections and microneedles on arrays | Aug 10, 2018 | Application |